Myonexus Launches Development of Gene Therapies Targeting Limb-Girdle MD – Muscular Dystrophy News
|
Myonexus Launches Development of Gene Therapies Targeting Limb-Girdle MD
Muscular Dystrophy News Launch plans include the accelerated development of five investigational gene therapies that have the potential to become the first standard-of-care therapies for LGMDs. Myonexus' pipeline includes three clinical-stage gene therapy programs (LGMD2E, … |
